Exit Wealth Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-53,008
Closed -$3.05M – 153
2026
Q2
$3.05M Buy
53,008
+8,037
+18% +$461K 1.39% 19
2026
Q1
$2.73M Sell
44,971
-1,025
-2% -$59.8K 1.4% 15
2025
Q4
$2.48M Buy
+45,996
New +$2.21M 1.47% 16

Other funds holding BMY

Exit Wealth Advisors's BMY Position: Q3 2026 in Review

Exit Wealth Advisors sold out of Bristol-Myers Squibb (BMY) in Q3 2026, closing a stake of 53,008 shares — an estimated $3.05M sold.

Exit Wealth Advisors first reported a position in BMY in Q4 2025 and held it in 3 quarters. The position peaked at $3.05M in Q2 2026. 2,570 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • Exit Wealth Advisors reported no remaining Bristol-Myers Squibb position as of Q3 2026 after selling out during the quarter.
  • Exit Wealth Advisors sold 53,008 Bristol-Myers Squibb shares in Q3 2026, an estimated $3.05M.
  • Exit Wealth Advisors first reported a position in Bristol-Myers Squibb in Q4 2025 and held it in 3 quarters.
  • Exit Wealth Advisors's Bristol-Myers Squibb position peaked at $3.05M in Q2 2026.
  • 2,570 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Exit Wealth Advisors's 13F filing for Q3 2026, filed 13 Nov 2026.